METTL3 is overexpressed in colorectal, gastric, and liver cancers, promoting cancer cell proliferation by inhibiting the tumor suppressor SOCS2 (Jiang et al., 2020; Xu et al., 2020; Chen et al., 2018). Here, SOCS2 is linked to liver cancer.